Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zhuling Duotang Jiaonang plus nucleos(t)ide analogues for low-level viremia in chronic hepatitis B
ChiCTR2200065999Phase 4Recruiting
- Sponsor
- Beijing YouAn Hospital
- Start
- Nov 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of polyporus polysaccharide in Chronic Hepatitis B (CHB) (2 arms), sponsored by Beijing YouAn Hospital. Primary endpoint: Magnitude of serum HBV DNA decline. Started Nov 2022; status: recruiting.
02
Drugs
polyporus polysaccharide
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2200065999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065999.